BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31185503)

  • 1. Antcin-A Modulates Epithelial-to-Mesenchymal Transition and Inhibits Migratory and Invasive Potentials of Human Breast Cancer Cells via p53-Mediated miR-200c Activation.
    Kumar KJS; Vani MG; Hsieh HW; Lin CC; Wang SY
    Planta Med; 2019 Jul; 85(9-10):755-765. PubMed ID: 31185503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.
    Si L; Jiang F; Li Y; Ye X; Mu J; Wang X; Ning S; Hu C; Li Z
    Mol Carcinog; 2015 Sep; 54(9):859-69. PubMed ID: 24729530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-200c inhibits metastasis of breast tumor via the downregulation of Foxf2.
    Zhang T; Wan JG; Liu JB; Deng M
    Genet Mol Res; 2017 Aug; 16(3):. PubMed ID: 28829888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis.
    Shi D; Guo L; Sun X; Shang M; Meng D; Zhou X; Liu X; Zhao Y; Li J
    Sci Rep; 2020 Apr; 10(1):6657. PubMed ID: 32313093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
    Lai YH; Liu WL; Lee TY; Kuo CW; Liu YR; Huang CY; Chen YH; Chen IL; Wu SH; Wang SC; Lee PY; Liu CC; Lo J; Chang YC; Kuo HF; Hsieh CC; Li CY; Liu PL
    Phytomedicine; 2023 Feb; 110():154597. PubMed ID: 36603340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
    Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
    Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance.
    Mutlu M; Raza U; Saatci Ö; Eyüpoğlu E; Yurdusev E; Şahin Ö
    J Mol Med (Berl); 2016 Jun; 94(6):629-44. PubMed ID: 27094812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.
    Kurata A; Yamada M; Ohno SI; Inoue S; Hashimoto H; Fujita K; Takanashi M; Kuroda M
    Oncol Rep; 2018 Jan; 39(1):91-100. PubMed ID: 29138864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cells.
    Manavalan TT; Teng Y; Litchfield LM; Muluhngwi P; Al-Rayyan N; Klinge CM
    PLoS One; 2013; 8(4):e62334. PubMed ID: 23626803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antrodin C inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via suppression of Smad2/3 and β-catenin signaling pathways.
    Kumar KJ; Vani MG; Chueh PJ; Mau JL; Wang SY
    PLoS One; 2015; 10(2):e0117111. PubMed ID: 25658913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c.
    Ye X; Jiang F; Li Y; Mu J; Si L; Wang X; Ning S; Li Z
    Cancer Sci; 2014 Jul; 105(7):875-82. PubMed ID: 24754877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
    Howe EN; Cochrane DR; Richer JK
    Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer.
    Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
    Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
    Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-200a negatively regulates TGF-β
    Guo R; Hao G; Bao Y; Xiao J; Zhan X; Shi X; Luo L; Zhou J; Chen Q; Wei X
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1087-F1095. PubMed ID: 29357421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the role of hsa-miR-200c in reversing the epithelial to mesenchymal transition in prostate cancer.
    Basu S; Chaudhary A; Chowdhury P; Karmakar D; Basu K; Karmakar D; Chatterjee J; Sengupta S
    Gene; 2020 Mar; 730():144264. PubMed ID: 31759982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.